42 studies found for:    " January 19, 2011":" February 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection
Condition: HIV Infections
Intervention:
22 Recruiting Safety of and Immune Response to Dolutegravir (GSK1349572) in HIV-1 Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: Dolutegravir (DTG) tablet formulation;   Drug: DTG oral pediatric granules taken as suspension or granules
23 Unknown  Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab
24 Completed
Has Results
Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
Condition: HIV-1 Infection
Intervention: Drug: FTC/RPV/TDF
25 Completed
Has Results
Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination
Conditions: HIV;   Rabies
Intervention: Biological: rabies vaccines on day 0 and 3
26 Unknown  Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
Condition: HIV
Interventions: Drug: Raltegravir;   Drug: Efavirenz
27 Active, not recruiting Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients
Condition: HIV
Intervention: Drug: MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir
28 Completed Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
29 Unknown  Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals
Condition: HIV-1 Infection
Intervention: Drug: Disulfiram
30 Active, not recruiting Microbicide Safety and Acceptability in Young Men
Conditions: High Risk MSM;   HIV Negative;   18-30 Years of Age
Interventions: Other: HEC Placebo Gel;   Drug: Tenofovir 1% Gel
31 Completed A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection
Condition: HIV Immune Restoration
Intervention:
32 Unknown  Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)
Condition: HIV-infected Children
Intervention: Drug: kaletra
33 Completed Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
Condition: Prevention of Infection With HIV-1
Intervention: Biological: ibalizumab (biologic/MAb) for SC Injection or placebo
34 Completed Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers
Conditions: Neisseria Gonorrhoeae Infection;   Chlamydia Trachomatis;   HIV
Interventions: Drug: Monthly antibiotic;   Drug: Monthly placebo
35 Active, not recruiting Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle
Condition: HIV
Interventions: Behavioral: FAmily CEntered (FACE) ACP;   Behavioral: Healthy Living Control
36 Active, not recruiting Safer Sex Intervention for Male Clients of Female Sex Workers in Tijuana, Mexico
Conditions: HIV;   Sexually Transmitted Diseases
Interventions: Behavioral: Hombre Seguro;   Behavioral: Didactic attention-control condition
37 Completed Pharmacokinetic Interactions Between DMPA and LPV/Rit Among HIV-Infected Women
Condition: HIV-1 Infection
Interventions: Drug: depo-medroxyprogesterone acetate;   Drug: Depo-medroxyprogesterone Acetate
38 Unknown  HIV Prevention in Very High Risk Men Who Have Sex With Men
Condition: Risk Reduction Behavior
Intervention: Behavioral: Cognitive-behavioral therapy
39 Completed Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
Condition: Healthy
Interventions: Drug: Maraviroc;   Drug: Fosamprenavir/ritonavir;   Drug: Maraviroc + Fosamprenavir/ritonavir
40 Completed TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions
Condition: Healthy
Interventions: Drug: Darunavir (DRV);   Drug: ritonavir

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
Indicates status has not been verified in more than two years